New Hyderabad office strengthens India footprint
Ribbon-cutting at EVA Holding’s new Hyderabad office. Credit: EVA Holding
Celebrating the launch of EVA Holding’s Hyderabad office. Credit EVA Holding
Celebrating the launch of EVA Holding’s Hyderabad office. Credit EVA Holding

Company news

New Hyderabad office strengthens India footprint

18 Aug, 2025

EVA Holding, a global leader in health and wellness, has officially opened a new office in Hyderabad, marking a key step in the company’s expansion across Asia. The office will act as a regional hub for Curium, EVA’s supply chain organisation, enhancing collaboration with international partners and supporting global supply operations.

This move follows EVA’s recent launch of its China office in June 2025, underscoring the company’s strategy to strengthen supply chain infrastructure and expand its footprint in major pharmaceutical markets.

“We are expanding globally to create greater access to healthcare solutions and strengthen partnerships in key regions,” said Riad Armanious, CEO of EVA Holding. “Our presence in India will unlock new opportunities for technology transfer, R&D collaboration, and innovation, complementing our operations across MENA and Europe.”

The Hyderabad office positions EVA to better serve local health systems, integrate with international partners, and support its broader mission of advancing healthcare worldwide.

More information online

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Real-time monitoring gives emergency responders greater visibility at high-stakes events
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
UK refining capacity falls to four plants after a second unplanned closure
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow